English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The article deals with the question of why the German authorities failed to reform drug regulation between 1871 and 1945, although it was urgently required due to the fundamental pharmaceutical change. The German drug regulation was initially dominated by non-state actors. The state was faced with numerous and powerful actors who represented completely different interests and standards, especially in health and economic policy. On the one hand, the reform of pharmaceutical law was blocked because the authorities were unable to balance these multiple normativities. On the other hand, the reform was complicated by external, non-medical norms and constraints.

Zwischen Gesundheit und Wirtschaft: Normen und Interessenkonflikte in der behördlichen Arzneimittelregulierung im Deutschen Reich 1871–1945